1. Home
  2. HCWB vs PAVS Comparison

HCWB vs PAVS Comparison

Compare HCWB & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.93

Market Cap

5.0M

Sector

Health Care

ML Signal

HOLD

Logo Paranovus Entertainment Technology Ltd.

PAVS

Paranovus Entertainment Technology Ltd.

HOLD

Current Price

$4.62

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
PAVS
Founded
2018
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.5M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
HCWB
PAVS
Price
$1.93
$4.62
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $35.00
N/A
AVG Volume (30 Days)
★ 818.2K
12.6K
Earning Date
05-15-2026
07-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $4,099,750.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.02
52 Week High
$5.61
$26.69

Technical Indicators

Market Signals
Indicator
HCWB
PAVS
Relative Strength Index (RSI) 38.72 46.78
Support Level $0.37 $3.86
Resistance Level $3.90 $5.55
Average True Range (ATR) 0.31 0.25
MACD -0.04 0.01
Stochastic Oscillator 19.20 56.30

Price Performance

Historical Comparison
HCWB
PAVS

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.

Share on Social Networks: